La corioretinopatia sierosa centrale: Una nuova manifestazione extradigestiva dell'Helicobacter pylori? Analisi di un caso clinico

Clinica Terapeutica

Volumn 152, Issue 6, 2001, Pages 393-397

  Giusti, C ^a,b  

^a Department of Obstetrics and Gynecology   (Italy)

^b NONE   (Italy)

Author keywords

Central serous chorioretinopathy; Helicobacter pylori; Retina

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHOROID DISEASE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MICROBIOLOGY; RETINA DISEASE;

ADULT; CHOROID DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; RETINAL DISEASES;

EID: 0035524436     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Albert DM, Jakobiec FA: Principles and practice of ophthalmology. Philadelphia, Saunders, 1994
2. Federman JL, Gouras P, Schubert H, et al.: Retina and vitreous. Textbook of Ophthalmology, vol. 9. London, Mosby, 1994
3. Farber MD, Lam S, Tessler HH, et al.: Reduction of macular edema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective cross-over study. Br J Ophthalmol 78: 4-7, 1994
4. Fishman GA, Gilbert LD, Anderson RJ, et al.: Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. Ophthalmology 101: 687-93, 1994
5. Mauguet-Faysse M, Kodjikian L, Quaranta M, et al.: Central serous chorioretinopathy and Helicobacter Pylori: a new possible etiological theory. Invest Ophthalmol Vis Sci 41: S783, 2000 (abstr. 4155)
6. Pannarale MR: La determinazione della correzione astigmatica. Indicazioni e tecniche d'uso di quadranti astigmometrici personali. Boll Ocul 56: 71-76, 1977
7. Giusti C, Forte R, Vingolo EM, et al.: Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study. Intern Ophthalmol (in press)
8. Peterson WL, Graham DY: Helicobacter pylori. In: Feldman M, Scharschmidt BF, Sleisenger MH (eds): Sleisenger & Fordtran's Gastrointestinal and liver disease (ed. 6), Philadelphia, Saunders, 1998, pp. 604-619
9. Chan AO, Chu KM, Yuen ST, et al.: Synchronous gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma in association with Helicobacter pylori infection: comparing reported cases between the East and West. Am J Gastroenterol 66: 1922-1924, 2001
10. Montalban C, Santon A, Boixeda D, et al.: Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long term results after sequential histologic and molecular follow-up. Haematologica 86: 609-617, 2001
11. Casella G, Buda CA, Maisano R, et al.: Complete regression of primary gastric MALT-lymphoma after double eradication Helicobacter pylori therapy: role and importance of endoscopie ultrasonography. Anticancer Res 21: 1499-1502, 2001
12. Henegan MA, McCarthy CF, Janulaityte D, et al.: Relationship of anti-Lewis X and anti-Lewis Y antibodies in serum samples from gastric cancer and chronic gastritis patients to helicobacter pylori-mediated autoimmunity. Infect Immun 69: 4774-4781, 2001
13. Moran AP, Prendergast MM: Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity. J Autoimmun 16: 241-256, 2001
14. Faller G, Kirchner T: Helicobacter pylori and antigastric autoimmunity, Pathologe 22: 25-30, 2001
15. Domek MJ, Netzer P, Prins B, et al.: Helicobacter pylori induces apoptosis in human epithelial gastric cells by stress activated protein kinase pathway. Helicobacter 6: 110-115, 2001
16. Yamaoka Y, Kodama T, Kita M, et al.: Relation between cytokines and helicobacter pylori in gastric cancer. Helicobacter 6: 116-124, 2001
17. Kim TI, Lee YC, Lee KH, et al.: Effects of nonsteroidal anti-inflammatory drugs on helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation and inflammator activity. Infect Immun 69: 5056-5063, 2001
18. Miehlke S, Yu J, Schuppler M, et al.: Helicobacter pylori vacA, iceA and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease. Am J Gastroenterol 96: 1008-1013, 2001
19. De Koster E, De Bruyne I, Langlet P, et al.: Evidence based medicine and extradigestive manifestations of Helicobacter Pylori. Acta Gastroenterol Belg 63: 388-392, 2000
20. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, et al.: Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 93: 937-941, 2001
21. Choe YH, Kwon YS, Yung MK, et al.: Helicobacter pylori-associated iron-deficiency anemia in adolescent female athletes. J Pediatr 139: 100-104, 2001
22. Cuoco L, Cammarota G, Jorizzo RA, et al.: Iron deficiency anemia, Helicobacter pylori infection and delayed pubertal growth. Arch Dis Child 83: 456, 2000 (letter)
23. Demir H, Saltik IN, Kocak N, et al.: Subnormal growth in children with Helicobacter pylori infection. Arch Dis Child 84: 89-90, 2001 (letter)
24. Kaptan K, Beyan C, Ural AU, et al.: Helicobacter pylori - is it a novel causative agent in vitamin B12 deficiency? Arch Intern Med 160: 1349-1353, 2000
25. Woods KF, Onuoha A, Schade RR, et al.: Helicobacter pylori infection in sickle cell disease. J Natl Med Assoc 92: 361-365, 2000
26. Seriolo B, Cutolo M, Zentilin P, et al.: Helicobacter pylori infection in rheumatoid arthritis. J Rheumatol 28: 1195-1196, 2001 (letter)
27. Nishimura M, Miyajima S, Okada N: Salivary gland MALT lymphoma associated with Helicobacter pylori infection in a patient with Sjogren's syndrome. J Dermatol 27: 450-452, 2000
28. Dobbs SM, Dobbs RJ, Weller C, et al.: Link between Helicobacter pylori infection and idiopathic parkinsonism. Med Hypotheses 55: 93-98, 2000
29. Hizal M, Tuzun B, Wolf R, et al.: The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria. Int J Dermatol 39: 443-445, 2000
30. Ernst PB, Pappo J: Preventive and therapeutic vaccines against Helicobacter pylori: current status and future challenges. Curr Pharm Des 6: 1557-1573, 2000